54 results on '"Ujike, H."'
Search Results
2. Late Living-Donor Kidney Transplantation After Living-Donor Lobar Lung Transplantation: Two Case Reports
3. Novel Preservation Method to Allow Expanded Use of Lungs in Uncontrolled Donation After Circulatory Death
4. Exosomal Microrna-17-5p and Microrna-150-5p in Plasma as Diagnostic Markers of Chronic Lung Allograft Dysfunction After Lung Transplantation
5. (258) Histidine-Rich Glycoprotein Ameliorates Lung Ischemia-Reperfusion Injury in a Mouse
6. Augmented Humoral Response to a Third And Fourth Dose of Mrna Sars-Cov-2 Vaccines in Lung Transplant Recipients
7. The Piccolo Intronic Single Nucleotide Polymorphism rs13438494 Regulates Dopamine and Serotonin Uptake and Shows Associations with Dependence-Like Behavior in Genomic Association Study
8. Genome-wide association study identifies a potent locus associated with human opioid sensitivity
9. P.6.c.006 Association between the tyrosine hydroxylase gene and patients with methamphetamine dependence
10. P.3.c.015 Improvement of serum prolactin after switching to blonanserin from risperidone in patients with schizophrenia: report of four cases
11. Association Study of Serine Racemase Gene with Methamphetamine Psychosis
12. Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia
13. Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese
14. Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence
15. Association Between 5HT1b Receptor Gene and Methamphetamine Dependence
16. SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study
17. Association Study of the Calcineurin A Gamma Subunit Gene (PPP3CC) and Methamphetamine-Use Disorder in a Japanese Population
18. Association Study betweenCasein Kinase 1 EpsilonGene and Methamphetamine Dependence
19. P.3.c.022 Analyses of genetic factors in olanzapine-induced weight gain in schizophrenic patients
20. Association of polymorphisms in the haplotype block spanning the alternatively spliced exons of the NTNG1 gene at 1p13.3 with schizophrenia in Japanese populations
21. Support for association of the PPP3CC gene with schizophrenia
22. PICK1 is not a susceptibility gene for schizophrenia in a Japanese population: Association study in a large case–control population
23. Possible association of ?-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia
24. RGS4 is not a susceptibility gene for schizophrenia in Japanese: Association study in a large case-control population
25. Association Study of the Dihydropyrimidinase-Related Protein 2 Gene and Methamphetamine Psychosis
26. No Association between CART (Cocaine‐ and Amphetamine‐Regulated Transcript) Gene and Methamphetamine Dependence
27. Association Study of the Tumor Necrosis Factor‐α Gene and Its 1A Receptor Gene with Methamphetamine Dependence
28. Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease
29. Linkage disequilibrium and association with methamphetamine dependence/psychosis of μ-opioid receptor gene polymorphisms
30. Serine racemase binds to PICK1: potential relevance to schizophrenia
31. Haplotype association between GABAA receptor γ2 subunit gene (GABRG2) and methamphetamine use disorder
32. A Polymorphism of DRD2 Gene and Brain Atrophy in Methamphetamine Psychosis
33. No Association Is Found between the Candidate Genes of t-PA/Plasminogen System and Japanese Methamphetamine-Related Disorder: A Collaborative Study by the Japanese Genetics Initiative for Drug Abuse
34. P.5.025 Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis
35. Another phenotype of frontotemporal dementia and parkinsonism linked to chromosome-17 (FTDP-17) with a missense mutation of S305N closely resembling Pick?s disease
36. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis
37. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
38. Effect of Character Size and Contrast on Readability of Visual Display Terminal
39. Visual acuity and minimum readable character size as function of age
40. Effects of Position and Contour Blurring of Cast Shadow on Depth Perception
41. Cerebrospinal fluid lactate and pyruvate concentrations in patients with Parkinson's disease and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)
42. BMY-14802 reversed the ? receptor agonist-induced neck dystonia in rats
43. Two Stages for Depth Integration of Motion Parallax
44. A relationship between a parallel search for colored targets and a given color difference
45. BMY-14802 reverses the reduction of striatal dopamine release induced by (+)-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine
46. BMY-14802 REVISES THE REDUCTION OF STRIATAL DOPAMINE RELEASE INDUCED BY (+)-3-[3-HYDROXYPHENYL]-N-(1-PROPYL)PIPERIDINE
47. Supersensitivity of σ receptors after repeated administration of cocaine
48. Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization
49. σ ANTAGONIST BMY 14802 BLOCKED THE INDUCTION OF METHAMPHETAMINE-INDUCED SENSTIZATION
50. Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.